Sacral Anesthetic Block During Labor Analgesia With a With a 27-G Whitacre Spinal Needle - Dural Puncture Epidural Technique vs Standard Epidural Technique: a Randomized Controlled Study.
Sacral Anesthetic Block During Labor Analgesia With a With a 27-G Whitacre Spinal Needle - Dural Puncture Epidural Technique vs Standard Epidural Technique: a Randomized Controlled Study.
Neuraxial labor analgesia is a very widely used technique for labor pain relief with a high efficacy and safety. EA (Epidural analgesia) can guarantee a proper control of pain in 95-100% of cases in the first stage of labor, but in the second stage his efficacy is not always adequate. DPEA (Dural Puncture Epidural Analgesia) is a variation of the conventional EA and technically a modified version of the CSE (Combined Spinal Epidural) analgesia.
When compared with the traditional EA, DPEA showed satisfying, effective and fast control of labor pain, no motor block and less need for anesthetic boluses given through the epidural catheter when the maintenance of analgesia was guaranteed with manual top-ups, as well as less request for extra boluses of anesthetic when PIEB (Programmed Intermittent Epidural Boluses) was chosen for the maintenance of analgesia. Studies proved that DPEA is a safe technique and no statistically significant incidence of side effects for mothers and fetuses was observed.
The hypothesis of this study is that a DPEA performed with a 27 G Whitacre spinal needle can especially improve the spread in the sacral region.
The primary outcome of this study is to evaluate whether the DPEA performed with a 27-G Whitacre spinal needle is more effective in ensuring satisfying analgesia as a result of a better sacral analgesic spread, compared to the traditional EA.
Labor pain is acute pain, with a sudden onset, limited duration, high intensity and an evolving character consisting of a visceral and a somatic component1. Many dermatomes are involved, unlike other pain syndromes.
In the first stage of labor, pain is caused by the contraction of the uterine fibers and by the stretching and dilation of the cervix and the lower uterine segment. When labor proceeds towards the active phase of the first stage, corresponding to a dilation of 3-4 cm, the pain becomes more severe, and extends to the contiguous dermatomes T10 and L1. The pain generated at this moment is visceral, dull, indistinct, difficult to locate, "referred" to skin areas far from the site of pain stimulation and most of the time as "back pain". When the uterine cervix is fully dilated, the second stage of labor begins: the pain is due to the distension and stretching of the perineal structures in conjunction with fetal progression. This late pain originates from the perineum (deep somatic pain) and is conducted by type A-delta and C somatic myelin fibers, that through the pudendal nerves reach the posterior horns of the spinal cord via the posterior roots of the 2nd, 3rd and 4th sacral nerve.
Currently, neuraxial analgesia is a very widely used technique for labor pain relief with a high efficacy and safety. Neuraxial analgesia is administered through:
EA (Epidural analgesia) can guarantee a proper control of pain in 95-100% of cases in the first stage of labor, but in the second stage his efficacy is not always adequate.
DPEA is a variation of the conventional EA and technically a modified version of the CSE analgesia.
It is performed by making an intentional puncture of the dura mater with a spinal needle, that is inserted in the Tuohy needle previously placed in the epidural space, without any administration of intrathecal medications.
If compared with the traditional EA, DPEA showed satisfying, effective and fast control of labor pain, no motor block and less need for anesthetic boluses given through the epidural catheter when the maintenance of analgesia was guaranteed with manual top-ups, as well as less request for extra boluses of anesthetic when PIEB (Programmed Intermittent Epidural Boluses) was chosen for the maintenance of analgesia.
Studies proved that DPEA is a safe technique and no statistically significant incidence of side effects for mothers and fetuses was observed.
DPEA can't provide the same analgesia's fast onset of the CSE, as no medications are given in the intrathecal space7-8, but authors agree that DPEA produces a better quality of labor analgesia compared with the EA.
The advantages of the DPEA include: less cases of wrong placement of the epidural catheter because of the confirmation given by the cerebrospinal fluid return, more hemodynamic stability, less risk of unilateral block and consequent manipulation and replacement of the epidural catheter, but most of all, the spontaneous translocation of a certain amount of anesthetic from the epidural to the intrathecal space through the little hole made intentionally in the dura mater could improve the strength of the analgesia both in the first and in the second stage of labor.
After the the acquisition of informed consent, all the nulliparous, singleton, vertex presenting pregnant women in labor between the 36th and 42nd gestational week and with less than 5 cm cervical dilation will be randomized according to a computer-generated random number sequence to receive DPEA or EA.
For all pregnant women, an 18 G intravenous access will be positioned before performing the neuro-axial technique and fluid therapy with Ringer Lactate 1000 ml will be started. Non-invasive multiparametric monitoring will include pulse oximetry, NIBP (Non Invasive Blood Pressure) and CTG (Cardiotocography).
The epidural space will be identified in both groups with a Tuohy 18 G needle using the loss of resistance technique to saline with liquid syringe and the spinal needle (Whitacre 27 G) inserted using the "needle through needle" technique. In patients randomized to receive a DPEA, a single spinal needle puncture will be performed with confirmation of LCR return, while in the EA group no hole will be drilled in the dura mater.
A 20 G multi-orifice epidural catheter will be inserted 5 cm inside the peridural space. After negative suction test for blood and LCR, an initial dose of 15 ml of ropivacaine 0.1% + sufentanil 0,5 mcg /ml will be administered through the peridural catheter. The maintenance of analgesia will be guaranteed through a PIEB machine, that will give to the patient every hour a single bolus of 10 ml of ropivacaine 0,1% + sufentanil 0,5 mcg/ml. In case of insufficient analgesia (breakthrough pain, VAS > 4) a rescue dose of 10 ml of 0.13% ropivacaine will be administered.
A rescue dose of 10 ml of 0.15% ropivacaine will be used to treat breakthrough pain at complete cervical dilatation.
The sample will be described in its clinical and demographic characteristics through descriptive statistics techniques. In particular, the qualitative variables will be represented with absolute and percentage frequency tables; continuous quantitative variables with normal distribution, with mean, standard deviation or 95%confidence interval; non-normal variables will be represented with minimum, maximum and mean.
Missing data will be presented in the form of n (%). The normality of continuous variables will be verified with the Shapiro-Wilk test and will be adopted opportune modifications when requested. The variance's similarity will be verified with the sd test. The primary objective will be assessed by comparing the incidence of the sensitive perineal block in two groups of patients at fixed time points, reporting risk ratios, 95% confidence interval and p values through the Chi square test or the Fisher test for estimated < 5 frequencies. The same method will be used to evaluate the secondary outcomes' incidence. To compare the differences between continuous quantitative variables with a normal distribution the Student t-test for independent samples will be applied. For variables with non-normal distribution the Mann-Whitney non parametric test for independent samples will be performed. A p value <0.05 will be considered significant.
All analyzes will be performed with the statistical software STATA IC 15.
Inclusion Criteria:
Exclusion Criteria: